Abstract
A series of 1,2,4-triazolo[1,5-a]pyrimidin-7(3H)-ones with excellent enzyme inhibition, improved isoform selectivity, and excellent inhibition of downstream phosphorylation of AKT has been identified. Several compounds in the series demonstrated potent (∼ 0.100μM IC50) growth inhibition in a PTEN deficient cancer cell line.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have